Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.7 D
Blech-Hermoni Y et al. (2016)
|
Xla Wt + celf1 MO
NF46 (RT-PCR)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + ccna2 + cdk2
NF18-19 (in situ hybridization)
|
|
|
|
Fig.3.a,b
Wylie LA et al. (2015)
|
Xla Wt + cdknx MO
NF18-19 (in situ hybridization)
|
|
|
|
Fig.1.a,b
Wylie LA et al. (2015)
|
Xla Wt + dnsnai2
NF17-18 (in situ hybridization)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1
NF18-19 (in situ hybridization)
|
|
|
|
Fig.7.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1
NF18-19 (in situ hybridization)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1 + ccna2 + cdk2
NF18-19 (in situ hybridization)
|
|
|
|
Fig.7.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1 + mycn
NF18-19 (in situ hybridization)
|
|
|
|
Fig.6.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1S62A,S88A,S185A,S189A,S202A,S218A + ccna2 + cdk2
NF18-19 (in situ hybridization)
|
|
|
|
Fig.7.a,b
Wylie LA et al. (2015)
|
Xla Wt + Mmu.ascl1S62A,S88A,S185A,S189A,S202A,S218A + mycn
NF18-19 (in situ hybridization)
|
|
|